
Journal of Organometallic Chemistry p. 35 - 42 (2018)
Update date:2022-08-11
Topics:
Tshabalala, Thandeka A.
Ojwach, Stephen O.
Reactions of 2-(2-methoxyethylimino)ethyl)phenol (HL1), 2-(2-hydroxyethylimino)ethyl)phenol (HL2), 2-(2-aminoethylimino)ethyl)phenol (HL3) and 2-(2-hydroxyethylimino)methyl)phenol (HL4) with [PdCl2(COD)] afforded the neutral palladium complexes [PdCl2(HL1)] (1), [PdCl2(HL2)] (2), [PdCl2(HL3)] (3), [PdCl2(HL4)] (4) respectively. Treatment of complex 1 with PPh3 gave the cationic complex [Pd(HL1)ClPPh3]+ (5), while reactions of 4 with Pd(OAc)2, in the presence of PPh3 and p-TsOH produced the corresponding palladium complex, [Pd(L1) (OTs) (PPh3)] (6). The molecular structure of 4a (derivative of 4) contained two bidentate anionic ligands (L4). Complexes 1–6 formed active catalysts in hydrogenation of alkenes and alkynes, in which the catalytic activities were largely dependent on the pendant donor atom of the ligand motif. Isomerization reactions were dominant in terminal alkenes hydrogenation reactions, while hydrogenation of alkynes to alkanes occurred in two steps via alkene intermediates. Kinetics data were consistent with homogeneous active species. Density functional theory studies supported the hemi-labile nature of the ligands, and offered insights into the catalytic activity trends observed.
View More
Huangshan Honghui Pharm Technology Co., Ltd.(expird)
website:http://www.honghuichem.com
Contact:18855958372
Address:Qingshan Wan No.1,Nanyuan Kou,SheXian Huangshan City,Anhui Province
Ceresking Ecology & Technology co.,ltd
Contact:86 22 66218397
Address:Room 1613, Zheshang Mansion, No. 1988, Yingbin Avenue, Binhai New District, Tianjin,China.
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Shandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Doi:10.1016/j.tetlet.2004.10.085
(2004)Doi:10.1039/P29740000577
(1974)Doi:10.1016/j.bmcl.2010.01.165
(2010)Doi:10.1021/jo00366a048
(1986)Doi:10.1021/ja306934b
(2012)Doi:10.1021/acsmedchemlett.8b00158
(2018)